Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yoshihiro Kawaoka
Affiliation
Influenza Research Institute, University of Wisconsin
ORCID
Career Start Year
1979
Papers
906
H Index
130
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38043095
Defining Distinct RNA-Protein Interactomes of SARS-CoV-2 Genomic and Subgenomic RNAs.
J Proteome Res
2024
36182075
Previous omicron infection may be protective against reinfection with omicron variant BA.5 for at least 5Â months.
Clin Microbiol Infect
2023
37635002
Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Vaccine
2023
37562033
An Antiviral Role for TRIM14 in Ebola Virus Infection.
J Infect Dis
2023
37631932
Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs.
Vaccines (Basel)
2023
37797027
Mapping SARS-CoV-2 antigenic relationships and serological responses.
Science
2023
37796612
Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine.
JCI Insight
2023
37749254
Host range, transmissibility and antigenicity of a pangolin coronavirus.
Nat Microbiol
2023
37515281
Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018-2021.
Viruses
2023
37578011
Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death.
J Infect Dis
2023
37876803
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate.
iScience
2023
35860221
Mapping SARS-CoV-2 antigenic relationships and serological responses.
bioRxiv
2023
37193320
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate.
Lancet Reg Health West Pac
2023
36959194
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Nat Commun
2023
37352827
Transmission and re-infection of Omicron variant XBB.1.5 in hamsters.
EBioMedicine
2023
37454219
In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir.
Nat Commun
2023
37288342
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents.
iScience
2023
37451629
Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors.
Antiviral Res
2023
37212288
Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
J Med Virol
2023
37448563
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.
iScience
2023
37043872
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters.
EBioMedicine
2023
37443091
Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
Virol J
2023
37379580
The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets.
J Infect Dis
2023
37209424
Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors.
J Antimicrob Chemother
2023
37112710
Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge.
Vaccines (Basel)
2023
37243179
Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird Markets.
Viruses
2023
37105204
Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures.
Lancet Microbe
2023
37376452
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.
Vaccines (Basel)
2023
37466314
Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
mBio
2023
37402789
In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir.
Nat Commun
2023
36967128
Addressing the Threat of Emerging Viral Infections.
Keio J Med
2023
37359748
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan.
One Health
2023
37293069
Defining distinct RNA-protein interactomes of SARS-CoV-2 genomic and subgenomic RNAs.
bioRxiv
2023
37461652
Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine.
Res Sq
2023
36754229
High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19.
Int J Infect Dis
2023
36724341
Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro. Reply.
N Engl J Med
2023
36724340
Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro.
N Engl J Med
2023
36625587
SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters.
mSphere
2023
36813909
Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection.
Sci Rep
2023
36476720
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
N Engl J Med
2023
36851749
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan.
Viruses
2023
36851516
The COVID-19 Pandemic-A Potential Role for Antivirals in Mitigating Pandemics.
Viruses
2023
36517323
Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.
Vaccine
2023
36875208
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.
Influenza Other Respir Viruses
2023
36841831
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
Nat Commun
2023
36935846
The accuracy of reverse genetics systems for SARS-CoV-2: Circular polymerase extension reaction versus bacterial artificial chromosome.
Influenza Other Respir Viruses
2023
36773622
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate.
Lancet Infect Dis
2023
36680238
Which Virus Will Cause the Next Pandemic?
Viruses
2023
36763096
Coronavirus Immunotherapeutic Consortium Database.
Database (Oxford)
2023
36567444
Are twindemics occurring?
Influenza Other Respir Viruses
2023
1 - 50 of 906
Column Actions
Search
Recommended Authors
Brook E Heaton
Duke University School of Medicine
Career Start Year
2012
Number of shared co-authors
2
Sebastian Giese
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year
2012
Number of shared co-authors
1
Marie O Pohl
Institute of Medical Virology, University of Zurich
Career Start Year
2012
Number of shared co-authors
2
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
13
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Career Start Year
2011
Number of shared co-authors
11
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2010
Number of shared co-authors
6
James Zengel
Stanford University School of Medicine
Career Start Year
2010
Number of shared co-authors
4
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year
2009
Number of shared co-authors
6
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
12
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
7
Giorgi Metreveli
Icahn School of Medicine at Mount Sinai
Career Start Year
2008
Number of shared co-authors
10
Juan Ayllon
Icahn School of Medicine at Mount Sinai
Career Start Year
2007
Number of shared co-authors
6
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
3
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
11
Qinshan Gao
Merck & Co., Inc.
Career Start Year
2005
Number of shared co-authors
3
Silke Stertz
Institute of Medical Virology, University of Zurich
Career Start Year
2004
Number of shared co-authors
6
Wan-Mui Chan
School of Clinical Medicine, The University of Hong Kong
Career Start Year
2003
Number of shared co-authors
0
Balaji Manicassamy
University of Iowa
Career Start Year
2002
Number of shared co-authors
13
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
33
Man-Seong Park
Korea University College of Medicine
Career Start Year
2001
Number of shared co-authors
5
Birgit Bradel-Tretheway
Washington State University
Career Start Year
2000
Number of shared co-authors
10
Megan L Shaw
Icahn School of Medicine at Mount Sinai
Career Start Year
2000
Number of shared co-authors
8
Rong Hai
University of California riverside
Career Start Year
1999
Number of shared co-authors
10
Judith G Alamares
Icahn School of Medicine at Mount Sinai
Career Start Year
1999
Number of shared co-authors
2
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
26
Adam S Lauring
University of Michigan ann arbor
Career Start Year
1995
Number of shared co-authors
10
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year
1994
Number of shared co-authors
13
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year
1993
Number of shared co-authors
14
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Career Start Year
1989
Number of shared co-authors
14
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
20
row(s) 1 - 30 of 30
Collaborators
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers
156
Masato Hatta
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers
84
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers
33
Shufang Fan
Influenza Research Institute, University of Wisconsin
Co-authored papers
31
Chengjun Li
Harbin Veterinary Research Institute
Co-authored papers
28
Yasuko Hatta
FluGen Inc.
Co-authored papers
23
Michael G Katze
University of Washington
Co-authored papers
21
Ralph S Baric
University of North Carolina
Co-authored papers
20
Michael S Diamond
Washington University School of Medicine
Co-authored papers
14
David H O'Connor
Co-authored papers
14
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers
12
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers
12
Hiroaki Kitano
Co-authored papers
12
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers
9
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers
9
James C Paulson
Co-authored papers
9
Bobbie-Jo M Webb-Robertson
Pacific Northwest National Laboratory
Co-authored papers
8
Thomas O Metz
Pacific Northwest National Laboratory
Co-authored papers
8
Christopher B Wilson
Drukier Institute for Children's Health
Co-authored papers
8
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers
7
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers
7
James E Crowe
Vanderbilt University Medical Center
Co-authored papers
7
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
7
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers
7
Ryan McBride
Co-authored papers
7
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Sean C Proll
Fred Hutchinson Cancer Research Center
Co-authored papers
6
Nicolas Tchitchek
Sorbonne University INSERM
Co-authored papers
6
Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers
6
Andrew Pekosz
Co-authored papers
6
1 - 30